ArticlePolymers2026
Glycine-Functionalized Polycaprolactone Electrospun Nanofibers as Bioactive Scaffolds for Skin Repair.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Chronic cutaneous ulcers pose a major clinical challenge due to persistent inflammation, impaired angiogenesis, and limited regenerative capacity, underscoring the need to develop bioactive scaffolds that mimic the extracellular matrix (ECM) and promote skin repair. In this study, electrospun Poly(ε-caprolactone) (PCL) scaffolds functionalized with 10% (PCLGLI10) and 20% (PCLGLI20) glycine were fabricated, physicochemically and mechanically characterized, and evaluated in combination with human Wharton's jelly mesenchymal stromal cells (hWJ-MSCs). Glycine incorporation reduced fiber diameter to the nanoscale range (140-155 nm) and increased scaffold porosity (~71-72%) while preserving mechanical properties compatible with skin. FTIR and X-ray diffraction analyses confirmed glycine incorporation and a polymorphic transition from α- to γ-glycine during electrospinning. Cell viability remained above 95% in all scaffolds; however, PCLGLI10 significantly enhanced cell proliferation, metabolic activity, and the secretion of VEGF and HGF, mediators associated with angiogenesis and tissue repair. Furthermore, in a guinea pig full-thickness wound model, the PCLGLI10+hWJ-MSCs construct promoted a modulated inflammatory response and more organized collagen deposition. These findings support the potential of glycine-functionalized electrospun scaffolds as a promising strategy for chronic cutaneous ulcer regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.